This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue.

      

You are about to leave a GSK website

Third party content disclaimers

 

You are about to leave a GSK website. By clicking this link, you will be taken to a website that is independently operated and not managed by GSK. The website you are linking to is not controlled or endorsed by GSK and GSK assumes no responsibility for the content on the website. If you wish to proceed, click "OK". If you do not wish to leave this website, click “CANCEL”.

OK

CANCEL

The Time is Now! Dry Run

5 October 2024, 16:00

05 Oct, 2024

Webcast

Register Now

The approach to asthma is ever-changing, especially with the onset of new data and changes in the current asthma management guidelines. Mild asthma in particular has proven to be a complicated matter. Knowing that inflammation and airway remodelling continues to be present across all severities of asthma (even mild asthma), it is imperative to address these underlying issues along with symptom control and exacerbation reduction. This launch of the shingles vaccine aims to discuss the burden of shingles and the importance of prevention in older adults and immunocompromised populations.

 

This has been applied for CPD accreditation pending MMA approval.

Speakers

 Speaker foto

Dr Kejal Hasmukharay

Consultant Geriatician, Universiti Malaya Medical Centre

Dr Kejal Hasmukharay is a geriatric fellow at the University Malaya Medical Centre (UMMC). She graduated from the prestigious Faculty of Medicine, University of Malaya and was selected for the Bright Sparks scholarship to pursue Internal Medicine in her alma mater. She then sub-specialized in Geriatric Medicine. Her special interests include in understanding immuno-senescence, infections in older persons as well as identifying pre-frail states in older persons. She is a great advocate of preventive medicine and is passionate on empowering older persons to embrace active and healthy ageing. She has also been awarded the CHIMERA fellowship to be trained in implementational science. She is a member of the Malaysian Society of Geriatric Medicine She has had contributed in the development of interim recommendations for the aged care facilities as well as an online infection control training program for aged cares in Malaysia.

 Speaker foto

Latha A/P Selvarajah

Head of Department & Consultant Dermatologist, Hospital Sultan Ismail

Dr Latha Selvarajah, an esteemed Consultant Dermatologist who is serving as the Head of the Dermatology Department at Hospital Sultan Ismail in Johor Bahru. Her remarkable contributions extend beyond her hospital role, as she currently leads dermatological services for the entire Johor State. Dr Latha is a distinguished alumna of the University of Malaya, where she earned her MBBS degree. Furthering her commitment to excellence, she pursued advanced studies, obtaining her MRCP and an Advanced Master of Dermatology from the renowned National University of Malaysia. Her impressive academic journey has been accompanied by a string of accolades, including the coveted Excellent Service Awards, and her exceptional expertise has been showcased through multiple successful poster presentations at local and regional events.

 Speaker foto

Peter Weisenseel

Senior Doctor and Head of the Department for Clinical Research, Dermatologikum Hamburg, Germany.

Dr. Peter Weisenseel, based at Dermatologikum Hamburg in Germany, is a seasoned Senior Doctor and the Head of the Department for Clinical Research since 2018, he has held key positions in renowned institutions, including being the Head of Medical Affairs at SCIderm/TFS GmbH and Medical Development Manager at Janssen-Cilag GmbH. He has a wealth of experience in chronic inflammatory skin diseases, ranging from psoriasis and atopic dermatitis to acne and rosacea. Dr. Weisenseel expertise extends to clinical study management, where he has played pivotal roles in over 65 clinical studies focusing on systemics and biologics for psoriasis and atopic dermatitis.

 Speaker foto

Leong Hoe Nam

Consultant Infectious Disease Physician<br>Mount Elizabeth Novena Hospital, Singapore

Dr Leong Hoe Nam is an Infectious Diseases Physician. He graduated from NUS in 1996 and obtained his MRCP and M Med in 2001. Thereafter, he began his advanced specialist training in infectious diseases. Dr Leong further pursued his interest in virology at the Royal Free and University College Medical School, London under a fellowship awarded by National Medical Research Council. In 2008 he was awarded a second research fellowship to train at the University of Columbia, New York, on emerging pathogens. Dr Leong was previously a consultant in the Department of Infectious Disease in SGH. Having left Singapore General Hospital, he continued his practice in Infectious Diseases at private Raffles Hospital before setting up his own clinic at Mount Elizabeth Novena Hospital.

Agenda

03.30 PM :–  Registration & Discover the Shingrix Experience

5.15 PM :–  Welcome Remark by Ruxandra Nastasa, General Manager, GSK Malaysia

5.30 PM :– Paving the way to a Healthy Aging Community by Dr Kejal Hasmukharay, Geriatician, University Malaya Medical Centre

5.45 PM :– Beyond Skin Deep : A Shingles Patient Story by Patient Testimonies

6.05 PM :– More Than Just A Rash : The Burden of Shingles by Dr Latha Selvarajah, Head of Department & Dermatologist, Hospital Sultan Ismail, Johor Bahru

6.25 PM :– Panel Discussion 1

6.45 PM :– Shingrix : Why Do We Need An Innovative HZ Vaccine? by Dr Peter Weisenseel, Senior Doctor and Head of the Department for Clinical Research, Dermatologikum Hamburg, Germany

6.45 PM :– Clinical Development of Shingrix in Older Adults and Immunocompromised Population by Dr Peter Weisenseel, Senior Doctor and Head of the Department for Clinical Research, Dermatologikum Hamburg, Germany

7.15 PM :– Shingrix Experience and Strategies for Effective Patient counselling by Dr Leong Hoe Nam, Consultant Infectious Disease Physician at Mount Elizabeth Novena Hospital, Singapore

7.35PM :– Panel Discussion 2

7.55 PM :– Q&A

8.10PM :– The Time is Now: Unveiling and Launching the Next-Gen Herpes Zoster Vaccine-Shingrix by Sri Murali Sivadason, Vaccines Business Unit Director, GSK Malaysia

8.30PM :– Dinner

This educational program is brought to you by GSK.

PM-MY-SGX-WCNT-240015 10/05